Category: General

Dark Money Group’s Survey Claims GOP Primary Voters Oppose State Contract Pharmacy Access Laws

July 31, 2025 Shannon Young, Associate Editor/Senior Writer Views

Dark money group Building America’s Future said it surveyed more than 1,000 likely GOP primary voters on their support for “expanding” the 340B program by states passing contract pharmacy access bills.

The dark money group behind a campaign targeting GOP-led states’ recent efforts to enact 340B contract pharmacy access laws released [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Alkermes, Novartis Exempt Additional States from 340B Contract Pharmacy Restrictions

July 29, 2025 Shannon Young, Associate Editor/Senior Writer Views

Alkermes is one of two drugmakers to recently announce new state exemptions to their 340B contract pharmacy restrictions.

Two major drugmakers recently announced new states that will be exempt from their 340B contract pharmacy restrictions following their enactment [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Merck, Eisai, Vertex to Refund 340B Covered Entities for Overcharges

July 29, 2025 Shannon Young, Associate Editor/Senior Writer Views

Merck, Eisai and Vertex will refund 340B covered entities that purchased certain medications between 2022 and 2025, according to notices posted on HRSA's website.

Three drugmakers recently announced refunds to 340B covered entities that purchased certain medications between 2022 and 2025 following recalculations of [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Budget Reconciliation’s Effects Could Shape Efforts to Reform 340B, Policy Experts Say at 340B Coalition Conference

July 24, 2025 Shannon Young, Associate Editor/Senior Writer Views

Tom O’Donnell (left) and Michael McCaughan (right) speak at the 340B Coalition Summer Conference in National Harbor, Md.

The debate over federal drug pricing reform could garner newfound attention on Capitol Hill now that Congress has wrapped up [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

OPA Director Touches on 340B Rebate Litigation and Other Key Matters at 340B Coalition Conference

July 22, 2025 Shannon Young, Associate Editor/Senior Writer Views

Office of Pharmacy Affairs (OPA) Director Chantelle Britton addresses 340B stakeholders during remarks to open the 340B Coalition’s annual summer conference in National Harbor, Md. on Monday.

A key federal regulator highlighted the Health Resources and Services Administration’s (HRSA) legal fight against proposed drugmaker 340B rebate models [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

340B PATIENTS Act Reintroduction Expected Soon, Hospital Trade Group Challenges Drug Industry Criticisms

July 22, 2025 Shannon Young, Associate Editor/Senior Writer Views

340B Health President and CEO Maureen Testoni speaks at the 340B Coalition's Summer Conference in National Harbor, Md. on Monday.

The leader of a major 340B hospital trade group heralded the forthcoming reintroduction of a federal bill that would codify [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

GSK Exempts New States from 340B Contract Pharmacy Restrictions, Teva Issues New Update on Restricted Drugs

July 22, 2025 Shannon Young, Associate Editor/Senior Writer Views

GSK and Teva recently announced new changes to their 340B contract pharmacy restrictions.

Two major drugmakers announced new changes to their 340B contract pharmacy restrictions in notices posted to 340B ESP’s website late [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Lilly, Indivior, Kedrion to Refund 340B Covered Entities for Overcharges, Others Announce NDC Changes

July 22, 2025 Shannon Young, Associate Editor/Senior Writer Views

Three drugmakers recently announced refunds to 340B covered entities, while two others announced NDC changes.

Three drugmakers are offering refunds to 340B covered entities that purchased certain drugs between 2022 and 2025 following recalculations of [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Advocates Warn New CMS Proposed Rule Could Hurt 340B Program, Be ‘First Step Towards Payment Cuts’

July 17, 2025 Shannon Young, Associate Editor/Senior Writer Views

Hospital groups and other 340B backers condemned proposals, which CMS included in its 900-plus page draft hospital outpatient prospective payment system and ambulatory surgical center rule released this week.

340B hospital advocates are raising concerns that a new Trump administration proposal to accelerate hospital outpatient payment cuts to offset [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Rethinking 340B: Where Compliance Ends and Strategy Begins

July 17, 2025 Sponsored Content Views

Turning Compliance into Strategy

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Staff Email

Site Footer Live